Key drivers for each region include: for North America, policies supporting alternative therapies, a mature ecosystem, and high investment in research and development; for Europe, a strong demographic demand for non-invasive treatments, favorable regulations, and a well-established healthcare system; for Asia Pacific, a large and growing population, increasing awareness of alternative therapies, and government initiatives to promote traditional medicine; for Latin America, rising demand for cost-effective treatments, improving infrastructure, and a growing middle class; and for Middle East & Africa, a growing awareness of alternative therapies, increasing investment in healthcare, and a large and young population.